226 related articles for article (PubMed ID: 17511385)
21. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
Matsubara S; Yamaji Y; Fujita T; Kanayama T; Yamadori I; Sato M; Fujita J; Shiotani T; Takahara J
Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
[TBL] [Abstract][Full Text] [Related]
23. Paraneoplastic syndromes associated with visual loss.
Ling CP; Pavesio C
Curr Opin Ophthalmol; 2003 Dec; 14(6):426-32. PubMed ID: 14615650
[TBL] [Abstract][Full Text] [Related]
24. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature.
Boeck K; Hofmann S; Klopfer M; Ian U; Schmidt T; Engst R; Thirkill CE; Ring J
Br J Dermatol; 1997 Sep; 137(3):457-60. PubMed ID: 9349350
[TBL] [Abstract][Full Text] [Related]
25. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen.
Maeda A; Maeda T; Liang Y; Yenerel M; Saperstein DA
Mol Vis; 2006 Aug; 12():885-91. PubMed ID: 16917481
[TBL] [Abstract][Full Text] [Related]
26. Cone dysfunction as a paraneoplastic syndrome associated with retinal antigens approximating 40 kiloDalton.
Parc CE; Azan E; Bonnel S; Sahel JA; Kaplan J; Thirkill CE
Ophthalmic Genet; 2006 Jun; 27(2):57-61. PubMed ID: 16754207
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a novel small cell lung carcinoma cell line with specific recoverin expression from a patient with cancer-associated retinopathy.
Kobayashi M; Ikezoe T; Uemura Y; Takeuchi T; Ueno H; Ohtsuki Y; Taguchi H
Lung Cancer; 2007 Jun; 56(3):319-26. PubMed ID: 17374419
[TBL] [Abstract][Full Text] [Related]
28. The cancer-associated retinopathy antigen is a recoverin-like protein.
Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
[TBL] [Abstract][Full Text] [Related]
29. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy.
Adamus G; Machnicki M; Seigel GM
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):283-91. PubMed ID: 9040460
[TBL] [Abstract][Full Text] [Related]
30. [Paraneoplastic retinopathy and anti-recoverin antibodies].
Bataller L; Graus F; Dalmau J
Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
[No Abstract] [Full Text] [Related]
31. Pathological roles of recoverin in cancer-associated retinopathy.
Ohguro H; Nakazawa M
Adv Exp Med Biol; 2002; 514():109-24. PubMed ID: 12596918
[TBL] [Abstract][Full Text] [Related]
32. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome.
Maeda A; Ohguro H; Nabeta Y; Hirohashi Y; Sahara H; Maeda T; Wada Y; Sato T; Yun C; Nishimura Y; Torigoe T; Kuroki Y; Sato N
Eur J Immunol; 2001 Feb; 31(2):563-72. PubMed ID: 11180121
[TBL] [Abstract][Full Text] [Related]
33. Two cases of cancer-associated retinopathy combined with small-cell lung cancer.
Sakamori Y; Kim YH; Okuda C; Togashi Y; Kinose D; Masago K; Mio T; Uji A; Mishima M
Jpn J Clin Oncol; 2011 May; 41(5):669-73. PubMed ID: 21385760
[TBL] [Abstract][Full Text] [Related]
34. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells.
Thirkill CE; FitzGerald P; Sergott RC; Roth AM; Tyler NK; Keltner JL
N Engl J Med; 1989 Dec; 321(23):1589-94. PubMed ID: 2555714
[No Abstract] [Full Text] [Related]
35. Choroidal neovascularization associated with cancer-associated retinopathy.
Querques G; Thirkill CE; Hagege H; Soubrane G; Souied EH
Acta Ophthalmol; 2010 Aug; 88(5):571-5. PubMed ID: 19141145
[TBL] [Abstract][Full Text] [Related]
36. [Paraneoplastic retinopathy associated with cutaneous melanoma. An update apropos of a case].
Rougier MB; Hostyn P; Bret-Dibat C; Delaunay MM; Riss I; Le Rebeller MJ
J Fr Ophtalmol; 1995; 18(5):396-403. PubMed ID: 7560778
[TBL] [Abstract][Full Text] [Related]
37. Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.
Bazhin AV; Dalke C; Willner N; Abschütz O; Wildberger HG; Philippov PP; Dummer R; Graw J; de Angelis MH; Schadendorf D; Umansky V; Eichmüller SB
Int J Cancer; 2009 Jan; 124(1):140-9. PubMed ID: 18814277
[TBL] [Abstract][Full Text] [Related]
38. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
[TBL] [Abstract][Full Text] [Related]
39. [Severe visual loss caused by autoimmune retinopathy].
ten Berge JC; Schreurs MW; Dufour-van den Goorbergh BC; de Witte PM; van Schooneveld MJ; Rothova A
Ned Tijdschr Geneeskd; 2015; 159():A8039. PubMed ID: 25654680
[TBL] [Abstract][Full Text] [Related]
40. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]